Parallax Volatility Advisers’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-33,246
Closed -$694K – 3510
2022
Q3
$694K Buy
33,246
+278
+0.8% +$5.79K ﹤0.01% 1874
2022
Q2
$684K Hold
32,968
– – ﹤0.01% 1782
2022
Q1
$554K Buy
32,968
+1,295
+4% +$22.6K ﹤0.01% 1873
2021
Q4
$633K Sell
31,673
-23,696
-43% -$446K ﹤0.01% 2079
2021
Q3
$1M Buy
55,369
+6,079
+12% +$139K ﹤0.01% 1971
2021
Q2
$1.33M Buy
49,290
+2,710
+6% +$75.8K ﹤0.01% 1806
2021
Q1
$1.4M Buy
46,580
+13,612
+41% +$464K ﹤0.01% 1921
2020
Q4
$948K Hold
32,968
– – ﹤0.01% 2199
2020
Q3
$804K Hold
32,968
– – ﹤0.01% 2073
2020
Q2
$590K Hold
32,968
– – ﹤0.01% 1918
2020
Q1
$268K Hold
32,968
– – ﹤0.01% 1916
2019
Q4
$435K Sell
32,968
-11
-0% -$133 ﹤0.01% 1785
2019
Q3
$392K Buy
32,979
+11
+0% +$204 ﹤0.01% 1677
2019
Q2
$806K Hold
32,968
– – ﹤0.01% 1348
2019
Q1
$1.05M Buy
+32,968
New +$1.17M ﹤0.01% 1264

Other funds holding CVET

Parallax Volatility Advisers's CVET Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 33,246 shares — an estimated $694K sold.

Parallax Volatility Advisers first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $1.4M in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Parallax Volatility Advisers reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 33,246 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $694K.
  • Parallax Volatility Advisers first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Parallax Volatility Advisers's Covetrus, Inc. Common Stock position peaked at $1.4M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.